⌕
Caris Life Sciences · CAI · Nasdaq
Tenet 40 · Weak
Compare
$21.00−8.85%At closeTenet 40 · Weak
$21.00−2.04 (−8.85%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Caris Life Sciences (CAI) Stock

Caris Life Sciences (CAI) closed at $21.00 on Nov 16, 2026; its Tenet Score is 40 of 100 against 313 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

32 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$21.00
Nov 16, 2026
Market cap
$6.8B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
70.8×
price ÷ earnings
52-week range
14.19 – 36.50
low → high · as of close, Nov 13, 2026
Tenet Score
40/100
Weak · 313 Healthcare peers

Industry: Services – Health

Caris Life Sciences Inc. scores 40/100. Weak. Value is the soft spot, trading at 71× earnings versus 313 Healthcare peers. Insufficient inputs: Tenet 40 is built from 3 of 4 pillars, from 70% of its inputs. Growth is left out because no growth rate could be measured.

Tenet Score · vs sector

n=313
40/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
12
Quality
61
Health
47
Growth
—

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Growth omitted — no data yet.
ValueFQualityCHealthDGrowth—MomentumB
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
10.6×
price to book value
P/S
6.5×
price to fiscal 2025 sales
ROE
17%
return on equity
Operating margin
5.6%
fiscal 2025, before interest and tax
Net margin
9.2%
of revenue kept
Current ratio
6.71
current assets to liabilities
Net debt / EBITDA
—
Withheld: this figure is outside the range we accept for its kind.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Caris Life Sciences Inc.

We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligenc…

Composite computed Nov 13, 2026 · peer basis: Healthcare (n=313) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 105 US ETFs · top wrappers by weightSee all ETFs holding CAI →

Similar-sized companies in Services – Health

The 5 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Caris Life Sciences in?

Caris Life Sciences is in the Healthcare sector and the Services – Health industry.

What is Caris Life Sciences' Tenet Score?

Caris Life Sciences' Tenet Score is 40 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.